Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PROTEINUDSALG ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 4.1% 4.1%   Bankruptcy risk   18.9% 22.5% 30.6% 15.4% 9.9% 4.5% 11.8% 11.8%   Credit score (0-100)   8 5 1 12 24 45 20 20   Credit rating   B B C BB BB BBB BB BB   Credit limit (kDKK)   -0.0 0.0 -0.0 -0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   755 840 1,064 0 0 0 0 0   Gross profit   110 199 29.4 155 582 657 0.0 0.0   EBITDA   -17.4 26.4 -115 -16.3 446 456 0.0 0.0   EBIT   -17.4 26.4 -115 -16.3 446 456 0.0 0.0   Pre-tax profit (PTP)   -23.6 19.4 -134.2 -38.9 430.4 427.9 0.0 0.0   Net earnings   -23.6 19.4 -134.2 -38.9 355.5 327.6 0.0 0.0   Pre-tax profit without non-rec. items   -23.6 19.4 -134 -38.9 430 428 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -46.3 -27.0 -161 -160 270 598 483 483   Interest-bearing liabilities   0.0 4.7 0.0 0.0 29.6 51.9 0.0 0.0   Balance sheet total (assets)   163 313 321 370 978 1,284 483 483   Net Debt   -12.7 -6.5 -39.0 -67.8 -283 -308 -483 -483     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   755 840 1,064 0 0 0 0 0   Net sales growth   13.6% 11.2% 26.7% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   110 199 29.4 155 582 657 0.0 0.0   Gross profit growth   141.5% 81.1% -85.2% 426.0% 276.1% 12.8% -100.0% 0.0%   Employees   0 0 0 3 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -33.3% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   163 313 321 370 978 1,284 483 483   Balance sheet change%   27.1% 92.3% 2.5% 15.2% 164.5% 31.3% -62.4% 0.0%   Added value   -17.4 26.4 -114.8 -16.3 445.7 455.9 0.0 0.0   Added value %   -2.3% 3.1% -10.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   2.0 3.0 4.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -2.3% 3.1% -10.8% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   -2.3% 3.1% -10.8% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -15.8% 13.3% -390.2% -10.5% 76.6% 69.4% 0.0% 0.0%   Net Earnings %   -3.1% 2.3% -12.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -3.1% 2.3% -12.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -3.1% 2.3% -12.6% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -9.7% 9.6% -27.9% -3.2% 59.1% 40.3% 0.0% 0.0%   ROI %   0.0% 1,127.3% -4,897.1% 0.0% 297.1% 95.8% 0.0% 0.0%   ROE %   -16.2% 8.1% -42.3% -11.3% 111.1% 75.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -22.1% -7.9% -33.4% -30.2% 27.7% 46.6% 100.0% 100.0%   Relative indebtedness %   27.7% 40.5% 45.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   26.0% 39.2% 41.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   73.0% -24.5% 33.9% 417.4% -63.6% -67.5% 0.0% 0.0%   Gearing %   0.0% -17.4% 0.0% 0.0% 10.9% 8.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 301.0% 829.5% 0.0% 103.3% 68.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.0   Current Ratio   0.8 0.9 0.7 0.7 1.4 1.9 0.0 0.0   Cash and cash equivalent   12.7 11.2 39.0 67.8 313.1 359.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   21.6% 37.1% 30.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -46.3 -28.9 -163.1 -160.1 270.4 599.6 0.0 0.0   Net working capital %   -6.1% -3.4% -15.3% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 -5 223 456 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 -5 223 456 0 0   EBIT / employee   0 0 0 -5 223 456 0 0   Net earnings / employee   0 0 0 -13 178 328 0 0